Global
Contact Us
Net sales of CHF 11.1 billion (2.9% at CER1) – growth acceleration in H2 2025 (+3.6% CER1) Core EBIT increased to CHF 349.0 million (6.7% at CER1) – stronger H2 2025 (+8.1% CER1) Core EBIT margin expanded by 0.1 percentage points to 3.2% (5th consecutive year) Free Cash Flow of CHF 215.5 million Dividend proposal of CHF 2.50 per share (+6.4%)2 and 9 M&A transactions announced in 2025 Mid-term roadmap confirmed
DKSH has been recognized as a Great Place to Work® in 16 key markets, surpassing the number of certified markets in the previous year. DKSH has also been named one of the “Fortune 100 Best Companies to Work For™ Southeast Asia 2025”. These achievements reaffirm DKSH’s work environment and underscore its ongoing commitment to fostering a great corporate culture.
DKSH partners with waterdrop®, to bring their hydration solution to the Australian market. This partnership brings together waterdrop®’s sustainable, innovative approach to hydration with DKSH’s strong market expertise and nationwide distribution capabilities to make healthier drinking habits more accessible to Australians.
DKSH has announced Natale Capri as the sole Head of the Business Unit Performance Materials, building on his more than ten years of experience as Business Unit Co-Head. Thomas Sul, the former Co-Head, will transition into retirement.
DKSH has achieved another milestone in its sustainability efforts, as the Science Based Targets initiative (SBTi) has officially validated its near-term and net zero targets. This approval reflects DKSH’s commitment to its climate ambitions and reinforces its goal of achieving net-zero emissions by 2050.
DKSH has signed an agreement to acquire Biomedic Science Material Joint Stock Company (“Biomedic”), a leading distributor of equipment and reagents used in the biotechnology and diagnostic market in Vietnam. With this transaction, DKSH Technology further extends its scientific solutions business in line with the Business Unit’s strategy to solidify its position as a leading scientific solutions provider in Asia and Beyond.
DKSH announced today that it has signed an agreement to acquire Invita (NZ) Limited in New Zealand and Invita Australia Pty Limited in Australia (“Invita”). With this transaction, DKSH Performance Materials enhances its capabilities in the attractive food and beverage market, particularly in the dairy and nutritional segments, and strengthens its position as a leading life science and industrial specialties distributor in Asia Pacific.
DKSH Business Unit Healthcare Launches a three-part whitepaper series to help healthcare and life science companies explore industry trends and current market pressures to re-think commercial go-to market approaches in the Asia Pacific region. The whitepaper series demonstrates how strategic Commercial Outsourcing partnerships are evolving to deliver sustainable growth, resource agility, and improved patient access – successfully harnessing the region’s growing USD 10 billion healthcare outsourcing opportunity.
Reach out to our Group Media Relations team for any inquiries.
Head, Investor and Media Relations & Sustainability, and Head, Finance Healthcare Own Brands
Manager, Group Media Relations
Contact us to discover new opportunities.